SLC43A2 and neoplasm: The same study found that the targeting and inhibition of the methionine transporter SLC43A2, which is highly expressed in tumor cells, resulted in the restoration of H3K79me2 histone modification in T cells, which led to higher checkpoint-induced tumor immunity [28].